Sign In
Buy CNCE
$8.37
+0 (+0%)
At Close: May 30, 2023
How Concert Pharmaceuticals (CNCE) Stock Stands Out in a Strong Industry
12:52pm, Friday, 22'nd May 2020
Concert Pharmaceuticals (CNCE) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Sphera Funds Management Ltd. Buys AstraZeneca PLC, Merck Inc, Pfizer Inc, Sells Biomarin ...
12:00am, Thursday, 14'th May 2020Subaru XV Review - The Impreza-based SUV | Finder
06:19am, Wednesday, 13'th May 2020
It's an Impreza-based SUV, with AWD, a trademark Boxer engine, the option of a hybrid, beefy suspension and ground clearance, and a well-reviewed off-road mode.
Edited Transcript of CNCE earnings conference call or presentation 30-Apr-20 12:30pm GMT
01:14am, Wednesday, 13'th May 2020
Q1 2020 Concert Pharmaceuticals Inc Earnings Call
Plans approved for city centre hotel as exciting images released
04:11pm, Tuesday, 12'th May 2020
The wider £200m Pall Mall development will include a 284-bed hotel and 400,000 sq ft of office space once complete
Concert Pharmaceuticals to Webcast Presentation at UBS Virtual Healthcare Conference
11:00am, Tuesday, 12'th May 2020
Concert will present a corporate overview at the 2020 UBS Virtual Global Healthcare Conference on May 19, 2020 at 3:00 p.m. ET.
Concert Pharmaceuticals to Webcast Presentation at UBS Virtual Healthcare Conference
12:00am, Tuesday, 12'th May 2020
Concert will present a corporate overview at the 2020 UBS Virtual Global Healthcare Conference on May 19, 2020 at 3:00 p.m. ET.
Electro-IT and Home & Deco retailers could expand their logistics spaces by over 50 percent - Business Review
10:46am, Thursday, 07'th May 2020
Electro-IT and Home & Deco online retailers take up approximately 370,000 square meters (sqm) of storage space and this volume could increase by at
Concert Pharmaceuticals, Inc. (CNCE) Q1 2020 Earnings Call Transcript
04:30am, Friday, 01'st May 2020
Good morning and welcome to Concert Pharmaceuticals' first quarter 2020 investor update. Joining me this morning with prepared remarks are Roger Tung, our President and CEO; Jim Cassella, our Chief D
Mizuho Securities Maintains Their Buy Rating on Concert Pharma (CNCE)
05:48pm, Thursday, 30'th Apr 2020
In a report released today, Difei Yang from Mizuho Securities maintained a Buy rating on Concert Pharma (CNCE), with a price target of $18.00. The
Concert Pharmaceuticals (CNCE) Reports Q1 Loss, Lags Revenue Estimates
12:45pm, Thursday, 30'th Apr 2020
Concert (CNCE) delivered earnings and revenue surprises of 5.41% and -65.00%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Hologic To Launch Coronavirus Test, Amarin's Strong Q1
11:19am, Thursday, 30'th Apr 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 29)• Arvinas Inc (NASDAQ: ARVN) • Biondvax Pharmaceu
Concert Pharmaceuticals Q1 EPS $(0.700) Beats $(0.780) Estimate
11:08am, Thursday, 30'th Apr 2020Concert Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Update on Clinical Programs
11:00am, Thursday, 30'th Apr 2020
Concert will host a conference call and webcast April 30, 2020, at 8:30 a.m. ET to provide an update on the Company and discuss first quarter results.
